Back to User profile » Prof. Dr. Wagdy Eldehna
Papers published by Prof. Dr. Wagdy Eldehna:
Synthesis and Biological Evaluation of Imidazopyridine-Isatin Hybrids as Inhibitors of Leishmania major Growth
El Hassab MA, Eldehna WM, Elsayed ZM, Elbadawi MM, Negmeldin AT, Balaha M, Nasralla SN, Monir R, Ibrahim TM, Abe M, Tawfik HO, Bekhit AA, Hemeda LR
Drug Design, Development and Therapy 2026, 20:570670
Published Date: 24 March 2026
Identification of Coumarin-Chalcone and Coumarin-Pyrazoline Derivatives as Novel Anti-Toxoplasma gondii Agents
Ebaid MS, Chyb M, Furlan V, Ibrahim HAA, Bren U, Gatkowska J, Dziadek J, Eldehna WM, Sabt A
Drug Design, Development and Therapy 2024, 18:5599-5614
Published Date: 4 December 2024
Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights
Al-Warhi T, El Kerdawy AM, Said MA, Albohy A, Elsayed ZM, Aljaeed N, Elkaeed EB, Eldehna WM, Abdel-Aziz HA, Abdelmoaz MA
Drug Design, Development and Therapy 2022, 16:1457-1471
Published Date: 16 May 2022
Design, Synthesis and Biological Evaluation of New HDAC1 and HDAC2 Inhibitors Endowed with Ligustrazine as a Novel Cap Moiety
Al-Sanea MM, Gotina L, Mohamed MFA, Grace Thomas Parambi D, Gomaa HAM, Mathew B, Youssif BGM, Alharbi KS, Elsayed ZM, Abdelgawad MA, Eldehna WM
Drug Design, Development and Therapy 2020, 14:497-508
Published Date: 4 February 2020
Novel quinazoline-based sulfonamide derivative (3D) induces apoptosis in colorectal cancer by inhibiting JAK2–STAT3 pathway
Al-Obeed O, Vaali-Mohammed MA, Eldehna WM, Al-Khayal K, Mahmood A, Abdel-Aziz HA, Zubaidi A, Alafeefy A, Abdulla M, Ahmad R
OncoTargets and Therapy 2018, 11:3313-3322
Published Date: 5 June 2018
Isatin-benzoazine molecular hybrids as potential antiproliferative agents: synthesis and in vitro pharmacological profiling
Abdel-Aziz HA, Eldehna WM, Keeton AB, Piazza GA, Kadi AA, Attwa MW, Abdelhameed AS, Attia MI
Drug Design, Development and Therapy 2017, 11:2333-2346
Published Date: 9 August 2017